Incidence of Secondary Sclerosing Cholangitis in Hospitalized Long COVID-19 Patients: A Retrospective Single Center Study.

Christoph R Werner Stefano FuscoKatharina KienzleStefanie DöbeleKerstin ArtznerNisar P MalekDoerte Wichmann Siri Goepel

Published in: Diagnostics (Basel, Switzerland) (2024)

SSC-COVID is an emerging disease in post-COVID patients with a high incidence in our single-center cohort. SSC-COVID should be considered as a differential diagnosis, if unclear cholangiopathy or cholestasis persists after SARS-CoV-2 infection.

Keyphrases

sars cov
coronavirus disease
respiratory syndrome coronavirus
risk factors